Gland Pharma

Healthcare

19 May, 2021

Gland Pharma buys assets of Vitane Biologics to boost Sputnik V Covid vaccine production

Generic injectables-focused Gland Pharma Ltd, majority owned by China’s Shanghai Fosun Pharmaceutical Group, said it has acquired the assets of ......

Markets

16 March, 2021

Indian shares end lower as banks drag; Gland Pharma jumps on vaccine deal

Indian shares gave up early gains to close lower on Tuesday, dragged down by losses in financial stocks, while Gland ......

General

03 October, 2019

Grapevine: Fosun to buy 2 Pfizer factories; Sunil Mittal to up stake in CG Power

Gland Pharma, owned by Chinese firm Fosun Pharma, has emerged as the front-runner to acquire the two factories in Chennai ......

Premium

Finance

10 May, 2018

KKR strikes year's first full exit from India portfolio

Private equity giant Kohlberg Kravis Roberts & Co. (KKR) has sold its entire stake in a private-sector lender, marking its ......

General

05 February, 2018

Blackstone among suitors for Orchid Pharma; Greenko eyes Essel's solar assets

Private equity giant Blackstone, drugmakers Strides Shasun and Nectar Lifesciences are ahead in the race to acquire debt-laden Orchid Pharma, ......

Premium

Healthcare

19 December, 2017

Flashback 2017: Pharma M&As hog limelight; multi-speciality hospitals get PE money

Large private equity investments in multi-specialty hospitals and sustained investor interest across the single-specialty space were the showstoppers in the ......

General

21 August, 2017

Gland Pharma looks to revise Fosun deal; Rosatom eyes Inox's wind turbine biz

The shareholders of Gland Pharma Ltd, including buyout firm KKR and Co., are now considering selling up to 74% under ......

TMT

02 March, 2017

MakeMyTrip-SAIF Partners is exit of the year: VCCircle Awards

Venture capital and growth equity investment firm SAIF Partners has won the News Corp VCCircle exit of the year award ......

Premium

General

29 December, 2016

Which PE firms scored biggest exit deals

Private equity firms had another bumper year in terms of exits, with stake sale activity most notable in the manufacturing ......

General

07 October, 2016

M&As emerge the most popular route for PE exits even as the number of deals slides in Q3

The number of private equity exits in the three months ended September hit the lowest in the past 17 quarters ......